Oramed Pharmaceuticals
ORMPOramed Pharmaceuticals, or Oramed (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem, Israel. Its shares are lis …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Oramed Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/4/2023 | Buy | Mayer, Arie | Director | $2.2 | $8,398 |
| 4/3/2023 | Buy | Mayer, Arie | Director | $2.2 | $11,120 |
| 3/16/2023 | Buy | Kidron, Nadav | President and CEO | $2.0 | $53,014 |
| 3/14/2023 | Buy | Rozov, Yadin | Director | $2.0 | $102,450 |
| 3/14/2023 | Sell | Kidron, Miriam | Chief Scientific Officer | $2.0 | $201,000 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)